Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Free Cash Flow (2021 - 2025)

PAVmed has reported Free Cash Flow over the past 5 years, most recently at -$1.5 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$1.5 million for Q4 2025, down 1788.89% from a year ago — trailing twelve months through Dec 2025 was -$5.2 million (up 78.81% YoY), and the annual figure for FY2025 was -$5.2 million, up 84.42%.
  • Free Cash Flow for Q4 2025 was -$1.5 million at PAVmed, down from -$903000.0 in the prior quarter.
  • Over the last five years, Free Cash Flow for PAVM hit a ceiling of $90000.0 in Q4 2024 and a floor of -$22.9 million in Q2 2022.
  • Median Free Cash Flow over the past 5 years was -$11.7 million (2024), compared with a mean of -$10.4 million.
  • Biggest five-year swings in Free Cash Flow: surged 100.75% in 2024 and later plummeted 1788.89% in 2025.
  • PAVmed's Free Cash Flow stood at -$18.1 million in 2021, then grew by 5.17% to -$17.1 million in 2022, then grew by 29.58% to -$12.1 million in 2023, then surged by 100.75% to $90000.0 in 2024, then plummeted by 1788.89% to -$1.5 million in 2025.
  • The last three reported values for Free Cash Flow were -$1.5 million (Q4 2025), -$903000.0 (Q3 2025), and -$1.2 million (Q2 2025) per Business Quant data.